Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Implications of the Gut Microbiome in Parkinson's Disease
Mohamed Elfil, Serageldin Kamel, Mohamed Kandil, et al.
Movement Disorders (2020) Vol. 35, Iss. 6, pp. 921-933
Closed Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
Stefano Romano, George M. Savva, Janis R. Bedarf, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 496
Role and Mechanism of Gut Microbiota in Human Disease
Yinwei Chen, Jinghua Zhou, Li Wang
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 446
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
Loredana Leggio, Greta Paternò, Silvia Vivarelli, et al.
Biomolecules (2020) Vol. 10, Iss. 9, pp. 1327-1327
Open Access | Times Cited: 92
The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease
Nitu Dogra, Ruchi Jakhmola Mani, Deepshikha Pande Katare
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 2, pp. 315-332
Closed Access | Times Cited: 85
Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability
Guilherme Ramos Meyers, Hanen Samouda, Torsten Bohn
Nutrients (2022) Vol. 14, Iss. 24, pp. 5361-5361
Open Access | Times Cited: 67
Oral Dysbiosis and Inflammation in Parkinson’s Disease
Vanessa Fleury, Alkisti Zekeridou, Vladimir Lazarević, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 2, pp. 619-631
Open Access | Times Cited: 65
Alterations of gut microbiota and metabolome with Parkinson's disease
Zhenzhen Yan, Fan Yang, Jingwei Cao, et al.
Microbial Pathogenesis (2021) Vol. 160, pp. 105187-105187
Closed Access | Times Cited: 62
The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease
Orsolya Inczefi, P Bacsúr, Tamás Resál, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 60
Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis
Júlio César Claudino dos Santos, Micael Porto Portela Lima, Gerly Anne de Castro Brito, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101812-101812
Closed Access | Times Cited: 54
Brain modulation by the gut microbiota: From disease to therapy
Sarmistha Mitra, Raju Dash, Amena Al Nishan, et al.
Journal of Advanced Research (2022) Vol. 53, pp. 153-173
Open Access | Times Cited: 51
Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson’s disease: An animal study
Zhenzhen Yan, Fan Yang, Linlin Sun, et al.
Brain Behavior and Immunity (2022) Vol. 106, pp. 307-321
Closed Access | Times Cited: 42
SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Journal of Neuroscience Research (2023) Vol. 101, Iss. 6, pp. 952-975
Closed Access | Times Cited: 35
Effect of Lacticaseibacillus paracasei strain Shirota supplementation on clinical responses and gut microbiome in Parkinson's disease
Xiaodong Yang, Xiaoqin He, Shaoqing Xu, et al.
Food & Function (2023) Vol. 14, Iss. 15, pp. 6828-6839
Open Access | Times Cited: 34
The Endotoxin Hypothesis of Parkinson's Disease
Guy C. Brown, Marta Camacho, Caroline H. Williams‐Gray
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1143-1155
Open Access | Times Cited: 30
Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease from Mice to Human
Martina Montanari, Paola Imbriani, Paola Bonsi, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1560-1560
Open Access | Times Cited: 30
Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence
Xiaoyan Liu, Yi Liu, Junlin Liu, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 4, pp. 833-845
Open Access | Times Cited: 29
The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 27
Machine learning models for diagnosis and prognosis of Parkinson's disease using brain imaging: general overview, main challenges, and future directions
Beatriz García Santa Cruz, Andreas Husch, Frank Hertel
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 26
Diet and the gut microbiome in patients with Parkinson’s disease
Dayoon Kwon, Keren Zhang, Kimberly C. Paul, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
Alexander Hull, Magda L. Atilano, Laith Gergi, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 12
Development of early diagnosis of Parkinson's disease: Illusion or reality?
M. V. Ugrumov
CNS Neuroscience & Therapeutics (2020) Vol. 26, Iss. 10, pp. 997-1009
Open Access | Times Cited: 68
The Add-On Effect of Lactobacillus plantarum PS128 in Patients With Parkinson's Disease: A Pilot Study
Chin‐Song Lu, Hsiu‐Chen Chang, Yi-Hsin Weng, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 53
Impact of Obstructive Sleep Apnea on Cognitive and Motor Functions in Parkinson's Disease
Mohamed Elfil, Eshak I. Bahbah, Mahmoud Mohamed Attia, et al.
Movement Disorders (2020) Vol. 36, Iss. 3, pp. 570-580
Closed Access | Times Cited: 51
Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease
Jonas Ghyselinck, Lynn Verstrepen, Frédéric Moens, et al.
International Journal of Pharmaceutics X (2021) Vol. 3, pp. 100087-100087
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top